Scancell Company
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.
Founded Date:
1996
Headquarters:
Nottingham, Nottingham, United Kingdom
Technology:
Drug Discovery
Employee Number:
11-50
Industry:
Personalized Medicine
Number Of Exists:
N/A
Funding Status:
IPO
Investor Type:
N/A
Investment Stage:
N/A